LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION April 16, 2015 TO: Honorable Myra Crownover, Chair, House Committee on Public Health FROM: Ursula Parks, Director, Legislative Budget Board IN RE:HB1483 by Zerwas (Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. The bill would amend the Occupations Code relating to the dispensing of aesthetic pharmaceuticals byphysicians and therapeutic optometrists; imposing fees. The Texas Optometry Board, Texas Medical Board, and Comptroller of Public Accounts indicate that any costs associated with implementation of the bill could be absorbed utilizing current resources. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:304 Comptroller of Public Accounts, 503 Texas Medical Board, 514 Optometry Board LBB Staff: UP, NB, NV, TWh
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION
April 16, 2015
TO: Honorable Myra Crownover, Chair, House Committee on Public Health FROM: Ursula Parks, Director, Legislative Budget Board IN RE:HB1483 by Zerwas (Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.), Committee Report 1st House, Substituted
TO: Honorable Myra Crownover, Chair, House Committee on Public Health
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: HB1483 by Zerwas (Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.), Committee Report 1st House, Substituted
Honorable Myra Crownover, Chair, House Committee on Public Health
Honorable Myra Crownover, Chair, House Committee on Public Health
Ursula Parks, Director, Legislative Budget Board
Ursula Parks, Director, Legislative Budget Board
HB1483 by Zerwas (Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.), Committee Report 1st House, Substituted
HB1483 by Zerwas (Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would amend the Occupations Code relating to the dispensing of aesthetic pharmaceuticals byphysicians and therapeutic optometrists; imposing fees. The Texas Optometry Board, Texas Medical Board, and Comptroller of Public Accounts indicate that any costs associated with implementation of the bill could be absorbed utilizing current resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 304 Comptroller of Public Accounts, 503 Texas Medical Board, 514 Optometry Board
304 Comptroller of Public Accounts, 503 Texas Medical Board, 514 Optometry Board
LBB Staff: UP, NB, NV, TWh
UP, NB, NV, TWh